{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:04:35Z","timestamp":1782961475175,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Kidney Foundation of Thailand"},{"name":"Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10157-016-1370-9","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T06:25:02Z","timestamp":1481955902000},"page":"926-931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients"],"prefix":"10.1007","volume":"21","author":[{"given":"Sumanee","family":"Prakobsuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supinda","family":"Sirilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotcharat","family":"Vipattawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pahnwat T.","family":"Taweesedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasant","family":"Sumethkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Kantachuvesiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinee","family":"Disthabanchong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"issue":"4","key":"1370_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2215\/CJN.07810910","volume":"6","author":"A Bellasi","year":"2011","unstructured":"Bellasi A, Mandreoli M, Baldrati L, Corradini M, Di Nicolo P, Malmusi G, et al. Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol. 2011;6(4):883\u201391. doi: 10.2215\/CJN.07810910 .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"23","key":"1370_CR2","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305(23):2432\u20139. doi: 10.1001\/jama.2011.826 .","journal-title":"JAMA"},{"issue":"1","key":"1370_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1681\/ASN.2012070713","volume":"24","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol. 2013;24(1):125\u201335. doi: 10.1681\/ASN.2012070713 .","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1370_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1681\/ASN.2009121293","volume":"21","author":"M Wolf","year":"2010","unstructured":"Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol. 2010;21(9):1427\u201335. doi: 10.1681\/ASN.2009121293 .","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1370_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","volume":"7","author":"P Evenepoel","year":"2007","unstructured":"Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y. Tertiary \u2018hyperphosphatoninism\u2019 accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant. 2007;7(5):1193\u2013200. doi: 10.1111\/j.1600-6143.2007.01753.x .","journal-title":"Am J Transplant"},{"issue":"5","key":"1370_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1744-9987.2011.00932.x","volume":"15","author":"H Kawarazaki","year":"2011","unstructured":"Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Ando K, Nakajima I, et al. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study. Ther Apher Dial. 2011;15(5):481\u20137. doi: 10.1111\/j.1744-9987.2011.00932.x .","journal-title":"Ther Apher Dial."},{"issue":"1","key":"1370_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/TP.0000000000000823","volume":"100","author":"M Wolf","year":"2016","unstructured":"Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, et al. A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation. 2016;100(1):184\u201393. doi: 10.1097\/TP.0000000000000823 .","journal-title":"Transplantation"},{"issue":"2","key":"1370_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2215\/CJN.06380611","volume":"7","author":"S Sirilak","year":"2012","unstructured":"Sirilak S, Chatsrisak K, Ingsathit A, Kantachuvesiri S, Sumethkul V, Stitchantrakul W, et al. Renal phosphate loss in long-term kidney transplantation. Clin J Am Soc Nephrol. 2012;7(2):323\u201331. doi: 10.2215\/CJN.06380611 .","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"1370_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bone.2012.06.027","volume":"51","author":"K Tomida","year":"2012","unstructured":"Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, et al. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone. 2012;51(4):729\u201336. doi: 10.1016\/j.bone.2012.06.027 .","journal-title":"Bone"},{"issue":"9","key":"1370_CR10","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/ndt\/gfq815","volume":"26","author":"K Praditpornsilpa","year":"2011","unstructured":"Praditpornsilpa K, Townamchai N, Chaiwatanarat T, Tiranathanagul K, Katawatin P, Susantitaphong P, et al. The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations. Nephrol Dial Transplant. 2011;26(9):2780\u20135. doi: 10.1093\/ndt\/gfq815 .","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1370_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.2215\/CJN.08241109","volume":"5","author":"P Evenepoel","year":"2010","unstructured":"Evenepoel P, Meijers B, Viaene L, Bammens B, Claes K, Kuypers D, et al. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2010;5(7):1268\u201376. doi: 10.2215\/CJN.08241109 .","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"1370_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10157-015-1117-z","volume":"19","author":"T Hirukawa","year":"2015","unstructured":"Hirukawa T, Kakuta T, Nakamura M, Fukagawa M. Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities. Clin Exp Nephrol. 2015;19(4):543\u201355. doi: 10.1007\/s10157-015-1117-z .","journal-title":"Clin Exp Nephrol."},{"issue":"2","key":"1370_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/TP.0000000000000583","volume":"99","author":"H Pihlstrom","year":"2015","unstructured":"Pihlstrom H, Dahle DO, Mjoen G, Pilz S, Marz W, Abedini S, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99(2):351\u20139. doi: 10.1097\/TP.0000000000000583 .","journal-title":"Transplantation"},{"issue":"4","key":"1370_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/ctr.12341","volume":"28","author":"IH Bleskestad","year":"2014","unstructured":"Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Goransson LG. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transplant. 2014;28(4):479\u201386. doi: 10.1111\/ctr.12341 .","journal-title":"Clin Transplant"},{"issue":"4","key":"1370_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000348376","volume":"37","author":"TF Hiemstra","year":"2013","unstructured":"Hiemstra TF, Brown AJ, Chaudhry AN, Walsh M. Association of calcium, phosphate and parathyroid hormone with renal allograft function: a retrospective cohort study. Am J Nephrol. 2013;37(4):339\u201345. doi: 10.1159\/000348376 .","journal-title":"Am J Nephrol"},{"issue":"4","key":"1370_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/SLA.0000000000001431","volume":"262","author":"I Lou","year":"2015","unstructured":"Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel R, et al. How well does renal transplantation cure hyperparathyroidism? Ann Surg. 2015;262(4):653\u20139. doi: 10.1097\/SLA.0000000000001431 .","journal-title":"Ann Surg"},{"issue":"11","key":"1370_CR17","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1185\/03007990802437943","volume":"24","author":"GT Schumock","year":"2008","unstructured":"Schumock GT, Andress D, E Marx S, Sterz R, Joyce AT, Kalantar-Zadeh K. Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients. Curr Med Res Opin. 2008;24(11):3037\u201348. doi: 10.1185\/03007990802437943 .","journal-title":"Curr Med Res Opin."},{"key":"1370_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2369-14-14","volume":"14","author":"K Chartsrisak","year":"2013","unstructured":"Chartsrisak K, Vipattawat K, Assanatham M, Nongnuch A, Ingsathit A, Domrongkitchaiporn S, et al. Mineral metabolism and outcomes in chronic kidney disease stage 2\u20134 patients. BMC Nephrol. 2013;14:14. doi: 10.1186\/1471-2369-14-14 .","journal-title":"BMC Nephrol."},{"key":"1370_CR19","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.08.011","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Kido R, Komaba H, Onishi Y, Yamaguchi T, Hasegawa T, et al. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding. Am J Kidney Dis. 2013;. doi: 10.1053\/j.ajkd.2013.08.011 .","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"1370_CR20","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/jn\/119.10.1423","volume":"119","author":"J Ritskes-Hoitinga","year":"1989","unstructured":"Ritskes-Hoitinga J, Lemmens AG, Danse LH, Beynen AC. Phosphorus-induced nephrocalcinosis and kidney function in female rats. J Nutr. 1989;119(10):1423\u201331.","journal-title":"J Nutr"},{"issue":"8","key":"1370_CR21","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","volume":"5","author":"W Gwinner","year":"2005","unstructured":"Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, et al. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant. 2005;5(8):1934\u201341. doi: 10.1111\/j.1600-6143.2005.00938.x .","journal-title":"Am J Transplant"},{"issue":"6","key":"1370_CR22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3177\/jnsv.43.627","volume":"43","author":"H Matsuzaki","year":"1997","unstructured":"Matsuzaki H, Uehara M, Suzuki K, Liu QL, Sato S, Kanke Y, et al. High phosphorus diet rapidly induces nephrocalcinosis and proximal tubular injury in rats. J Nutr Sci Vitaminol (Tokyo). 1997;43(6):627\u201341.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"1","key":"1370_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/j.ajkd.2007.03.005","volume":"50","author":"A Beyea","year":"2007","unstructured":"Beyea A, Block C, Schned A. Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am J Kidney Dis. 2007;50(1):151\u20134. doi: 10.1053\/j.ajkd.2007.03.005 .","journal-title":"Am J Kidney Dis"},{"key":"1370_CR24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.08.029","author":"AR Chang","year":"2016","unstructured":"Chang AR, Miller ER 3rd, Anderson CA, Juraschek SP, Moser M, White K, et al. Phosphorus additives and albuminuria in early stages of CKD: a randomized controlled trial. Am J Kidney Dis. 2016;. doi: 10.1053\/j.ajkd.2016.08.029 .","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"1370_CR25","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","author":"N Voormolen","year":"2007","unstructured":"Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant. 2007;22(10):2909\u201316. doi: 10.1093\/ndt\/gfm286 .","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1370_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1681\/ASN.2010080894","volume":"22","author":"M Wolf","year":"2011","unstructured":"Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol. 2011;22(5):956\u201366. doi: 10.1681\/ASN.2010080894 .","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1370_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1432-2277.2006.00436.x","volume":"20","author":"ES Schaeffner","year":"2007","unstructured":"Schaeffner ES, Fodinger M, Kramar R, Sunder-Plassmann G, Winkelmayer WC. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int. 2007;20(3):247\u201355. doi: 10.1111\/j.1432-2277.2006.00436.x .","journal-title":"Transpl Int."},{"issue":"3","key":"1370_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1399-0012.2010.01292.x","volume":"25","author":"J Moore","year":"2011","unstructured":"Moore J, Tomson CR, Tessa Savage M, Borrows R, Ferro CJ. Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation. Clin Transplant. 2011;25(3):406\u201316. doi: 10.1111\/j.1399-0012.2010.01292.x .","journal-title":"Clin Transplant"},{"issue":"11","key":"1370_CR29","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.2215\/CJN.01880213","volume":"8","author":"LC Baia","year":"2013","unstructured":"Baia LC, Humalda JK, Vervloet MG, Navis G, Bakker SJ, de Borst MH, et al. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013;8(11):1968\u201378. doi: 10.2215\/CJN.01880213 .","journal-title":"Clin J Am Soc Nephrol."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1370-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T16:39:45Z","timestamp":1568651985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1370-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1370-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}